Arnaud Grenier

USPTO Granted Patents = 14 (Patent Applications = 4)

CIPO Patents = 5 (Patent Applications = 3)

EPO Patents = 7 (Patent Applications = 8)

Average Co-Inventor Count = 2.7

ph-index = 5

Forward Citations = 308(Granted Patents)

Location History:

Breaute, FR (2014)
Steinbrunn le Haut, FR (2007 - 2018)

Company Filing History:

9 out of 16

Antares Pharma Ipl Ag

Les Laboratoires Servier

patents

4. 1 out of 36

The Population Council, Inc.

patents

where one patent can have more than one assignee

Years Active: 2007-2018

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10117829 - Diclofenac formulations (2018-11-06),

2. 9999590 - Diclofenac formulations (2018-06-19),

3. 9682087 - Nestorone®/estradiol transdermal gel (2017-06-20),

4. 8980309 - Transdermal testosterone formulation for minimizing skin residues (2015-03-17),

5. 8980290 - Transdermal compositions for anticholinergic agents (2015-03-17),

6. 8895053 - Testosterone formulations (2014-11-25),

7. 8865915 - Process for the preparation of the L-arginine salt of perindopril (2014-10-21),

8. 8835652 - Delta crystalline form of the arginine salt of perindopril, a process for its preparation, and pharmaceutical compositions containing it (2014-09-16),

9. 8652491 - Transdermal compositions for anticholinergic agents (2014-02-18),

10. 7470433 - Formulations for transdermal or transmucosal application (2008-12-30),

11. 7425340 - Permeation enhancing compositions for anticholinergic agents (2008-09-16),

12. 7387788 - Pharmaceutical compositions of nicotine and methods of use thereof (2008-06-17),

13. 7335379 - Transdermal pharmaceutical formulation for minimizing skin residues (2008-02-26),

14. 7198801 - Formulations for transdermal or transmucosal application (2007-04-03),

Title: Arnaud Grenier: Innovator in Diclofenac Formulations

Introduction

Arnaud Grenier is a notable inventor based in Steinbrunn le Haut, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of improved formulations for diclofenac. With a total of 14 patents to his name, Grenier's work has had a meaningful impact on pain management therapies.

Latest Patents

Among his latest innovations, Grenier has developed advanced diclofenac gel formulations. These formulations aim to enhance the efficacy and absorption of diclofenac, a widely used nonsteroidal anti-inflammatory drug (NSAID). His work in this area demonstrates a commitment to improving patient outcomes through innovative pharmaceutical solutions.

Career Highlights

Throughout his career, Grenier has worked with reputable companies such as Antares Pharma and Ferring B.V. His experience in these organizations has allowed him to refine his skills and contribute to the development of cutting-edge medical products. His dedication to innovation is evident in the patents he has secured.

Collaborations

Grenier has collaborated with talented professionals in the field, including Dario Norberto R Carrara and Celine Besse. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of his inventions.

Conclusion

Arnaud Grenier stands out as a prominent inventor in the pharmaceutical industry, particularly for his advancements in diclofenac formulations. His contributions continue to shape the landscape of pain management therapies, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.